secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001388658-24-000165
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm Q3 revenue $147.5M (+18% YoY); gross margin 68.8% up 260 bps
--------------------------------------------------------------------

- Revenue $147.5M, up 18% YoY; gross profit $101.5M (+23%); gross margin 68.8% vs 66.2%
- Record quarterly registration volume; record new account openings in US; UK billable registrations >10,000
- FDA 510(k) clearance for Zio AT updates; commercial launch in Austria, Netherlands, Switzerland, Spain; Japan PMDA approval
- Technology license agreement with BioIntelliSense for multi-sensor capabilities; recognized $32.1M IPR&D charge
- Unrestricted cash $522.0M at Sep 30; cumulative one million patients registered for Zio monitor

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000165/0001388658-24-000165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000165/irtc-20241030.htm
  HTML page:      https://secwatch.observer/filing/0001388658-24-000165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer